CoDiagnostics secures its first patent for the Co-Dx PCR platform in Australia, strengthening IP protection as the point-of-care system awaits regulatory clearance.

The World Health Organization (WHO) has reached a pivotal moment in the fight against COVID-19 by prequalifying the first two rapid antigen diagnostic tests for SARS-CoV-2. This groundbreaking ...

Co-Diagnostics receives Australian patent covering Co-Dx PCR platform technologies for nucleic acid detection and analysis: Salt Lake City Wednesday, December 31, 2025, 11:00 Hrs ...

In a significant development in the fight against COVID-19, the World Health Organization (WHO) has prequalified two rapid antigen tests for detecting the virus. This landmark decision, announced last ...

Kerala faces a third year of high leptospirosis deaths. Learn about the spread, prevention, and urgent need for timely ...

Amoebic meningoencephalitis caused more deaths than flu (influenza) and rabies in the state in 2025. The health department ...

Tempus AI, Inc. (NASDAQ:TEM) is among the 12 Best Genomics Stocks to Invest In. TheFly reported on December 22, 2025, that ...

Future Market Insights, Inc. (FMI) is an ESOMAR-certified, ISO 9001:2015 market research and consulting organization, trusted ...

In this past year, we’ve seen the IPO market stabilize after several years of large-scale uncertainties – think post-COVID ...

On Oct. 31, the National Veterinary Services Laboratories confirmed findings of vesicular stomatitis New Jersey virus (VSNJV) ...

EST Co-Diagnostics (CODX) trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving breaking ...